Clinical Trials Logo

Advanced Cervical Carcinoma clinical trials

View clinical trials related to Advanced Cervical Carcinoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05521997 Not yet recruiting - Cervical Cancer Clinical Trials

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Start date: April 30, 2024
Phase: Phase 2
Study type: Interventional

Advanced cervical cancer patients treated with standard of care (SOC) chemoradiation plus glutaminase inhibition with telaglenastat (CB-839) will have increased progression-free survival (PFS) compared to historical rates for patients receiving SOC chemoradiation alone.